netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

Zika Virus Found in Tears

Researchers publish critical findings from Zika mouse model, raising the possibility of new avenues of transmission, as well as confirming the virus' ability to induce cell death in eyes

Research to Prevent Blindness (RPB)-funded researchers at Washington University School of Medicine in St. Louis published a study that shows that genetic material from the Zika virus has been found in tears. The study, fast-tracked for publication in Cell Reports, was conducted in mice, thereby creating an animal model for studying transmission and
treatment of this alarming virus.

Human tear

Photo credit: Robert Boston at Washington University 

The study, published Sept. 6, describes the effect of Zika virus infection on the eyes of mouse fetuses, newborns and adults and raises the possibility that the eye can function as a reservoir for Zika. Adult mouse models confirm that the virus can infect specific regions of the eye, resulting in uveitis and conjunctivitis (a symptom also observed in human patients).

The important question of whether Zika found in the human eye is infectious, through tears or any other medium, needs to be determined through further study. The researchers now are currently planning complementary studies in human patients infected with the virus.

"Even though we didn't find live virus in mouse tears, that doesn't mean that it couldn't be infectious in humans," said Jonathan J. Miner, MD, PhD, an instructor in medicine and paper's lead author. "There could be a window of time when tears are highly infectious, and people are coming in contact with it and able to spread it."

"We are planning studies in people to find out whether infectious virus persists in the cornea, because that would have implications for corneal transplantation," said Rajendra S. Apte, MD, PhD, the Paul A. Cibis Distinguished Professor of Ophthalmology and Visual Science, and one of the study's senior authors. 

Even if human tears do not turn out to be infectious, the researchers' detection of live viruses in the eye and viral RNA in tears still has practical benefits. Human tears potentially could be tested for viral RNA or antibodies, a less painful way to diagnose recent Zika infection than drawing blood. The mouse eye could be used to test anti-Zika drugs, and once an effective treatment has been found, dosing in the eye would avoid side effects such as liver toxicity.

Read the Press Release

Read the Study

Related News: Feature Story

Electric Fields ‘Steer’ Neural Stem Cells

New RPB-supported research provides hope for transplants of neural stem cells as future treatment for brain injuries.

Read More

 

July is Dry Eye Awareness Month

Dry eye, a global problem affecting more than 30 million people in the U.S. alone, occurs when the eye does not produce tears properly or when the tears are not of the correct consistency and evaporate too quickly.

Read More

 

Researchers Identify Biomarker for Glaucoma Damage

The RPB-supported researchers hope their finding will lead to tests to identify cell damage before irreversible vision loss.

Read More

 

Working Together to Fund Scientific Research for Eye Health

More than 30 private and public funders of vision research came together in Washington DC to discuss ways to maximize their support of scientific research in light of new recommendations and a changing environment.

Read More

 

Making the case that ‘Science Is For All’

An RPB Trustee pens a powerful Op-Ed on the need to support scientific research through the National Institutes of Health.

Read More

 

RPB AWARDS $5.4 MILLION IN GRANTS

The latest grant cycle supports eye research related to a variety of diseases and conditions.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.